世界の神経外科製品市場:医療機器パイプライン分析2016

【英語タイトル】Neurosurgical Products - Medical Devices Pipeline Assessment, 2016

GlobalDataが出版した調査資料(GDME0287EPD)・商品コード:GDME0287EPD
・発行会社(調査会社):GlobalData
・発行日:2016年12月1日
・ページ数:169
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥872,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,308,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、神経外科製品のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・神経外科製品の概要
・神経外科製品の開発動向:開発段階別分析
・神経外科製品の開発動向:セグメント別分析
・神経外科製品の開発動向:領域別分析
・神経外科製品の開発動向:規制Path別分析
・神経外科製品の開発動向:承認日(推定)別分析
・企業別神経外科製品の開発動向(パイプライン製品、進行中の治験)
・神経外科製品の最近動向
【レポートの概要】

Neurosurgical Products – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Neurosurgical Products – Medical Devices Pipeline Assessment, 2016″ provides an overview of Neurosurgical Products currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurosurgical Products pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Neurosurgical Products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Neurosurgical Products and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Neurosurgical Products under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Introduction 12
2.1 Neurosurgical Products Overview 12
3 Products under Development 13
3.1 Neurosurgical Products – Pipeline Products by Stage of Development 13
3.2 Neurosurgical Products – Pipeline Products by Segment 14
3.3 Neurosurgical Products – Pipeline Products by Territory 15
3.4 Neurosurgical Products – Pipeline Products by Regulatory Path 16
3.5 Neurosurgical Products – Pipeline Products by Estimated Approval Date 17
3.6 Neurosurgical Products – Ongoing Clinical Trials 18
4 Neurosurgical Products – Pipeline Products under Development by Companies 19
4.1 Neurosurgical Products Companies – Pipeline Products by Stage of Development 19
4.2 Neurosurgical Products – Pipeline Products by Stage of Development 21
5 Neurosurgical Products Companies and Product Overview 23
5.1 Accurexa Inc. Company Overview 23
5.1.1 Accurexa Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.2 Augusta University Company Overview 24
5.2.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview 24
5.3 BioArctic Neuroscience AB Company Overview 25
5.3.1 BioArctic Neuroscience AB Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 C2C Development, LLC Company Overview 27
5.4.1 C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Carnegie Mellon University Company Overview 28
5.5.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Carthera SAS Company Overview 29
5.6.1 Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Cizeta Surgical Company Overview 32
5.7.1 Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 Cornell University Company Overview 33
5.8.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 DiversiLabs, LLC Company Overview 34
5.9.1 DiversiLabs, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Elekta AB Company Overview 36
5.10.1 Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 36
5.11 Hadassah Medical Center Company Overview 38
5.11.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 38
5.12 InSightec Ltd Company Overview 39
5.12.1 InSightec Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
5.13 Integra LifeSciences Holdings Corp Company Overview 47
5.13.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 47
5.14 International HIFU Company Overview 51
5.14.1 International HIFU Pipeline Products & Ongoing Clinical Trials Overview 51
5.15 JetGuide Ltd. Company Overview 52
5.15.1 JetGuide Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
5.16 Mayo Clinic US Company Overview 53
5.16.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 53
5.17 Medprin Regenerative Medical Technologies Co Ltd Company Overview 55
5.17.1 Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.18 Medtronic plc Company Overview 56
5.18.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56
5.19 Monteris Medical Inc Company Overview 60
5.19.1 Monteris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.20 MRC Systems GmbH Company Overview 62
5.20.1 MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 62
5.21 NICO Corporation Company Overview 63
5.21.1 NICO Corporation Pipeline Products & Ongoing Clinical Trials Overview 63
5.22 Optiscan Imaging Limited Company Overview 64
5.22.1 Optiscan Imaging Limited Pipeline Products & Ongoing Clinical Trials Overview 64
5.23 PediaWorks Inc Company Overview 66
5.23.1 PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview 66
5.24 Replication Medical Inc Company Overview 67
5.24.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67
5.25 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 68
5.25.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 68
5.26 StereoTools SA Company Overview 69
5.26.1 StereoTools SA Pipeline Products & Ongoing Clinical Trials Overview 69
5.27 The Swedish Neuroscience Institute Company Overview 70
5.27.1 The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview 70
5.28 The University of Utah Company Overview 71
5.28.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 71
5.29 University of California San Francisco Company Overview 73
5.29.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 73
5.30 University of Colorado Company Overview 74
5.30.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 74
5.31 University of Maryland Baltimore Company Overview 75
5.31.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 75
5.32 University of South Florida Company Overview 76
5.32.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 76
5.33 University of Texas Medical Branch at Galveston Company Overview 77
5.33.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 77
5.34 Vanderbilt University Company Overview 78
5.34.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 78
5.35 Xylos Corporation Company Overview 80
5.35.1 Xylos Corporation Pipeline Products & Ongoing Clinical Trials Overview 80
6 Neurosurgical Products- Recent Developments 81
6.1 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 81
6.2 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 83
6.3 Nov 16, 2016: New Head of the ZEISS Semiconductor Manufacturing Technology Business Group 84
6.4 Nov 15, 2016: Penumbra Announces Resignation of Board Member 85
6.5 Nov 10, 2016: Monteris Medical Raises USD6.8 Million in Venture Financing 85
6.6 Nov 04, 2016: MRI Interventions Announces 2016 Third Quarter and Nine Month Results 85
6.7 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results 89
6.8 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017 89
6.9 Oct 27, 2016: Stryker reports third quarter 2016 results 90
6.10 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 91
6.11 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 92
6.12 Oct 25, 2016: Bard Announces Third Quarter Results 93
6.13 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 94
6.14 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 95
6.15 Oct 12, 2016: Transgenomic to Raise up to USD7 Million in Private Placement of Shares 96
6.16 Sep 28, 2016: Elekta’s new Leksell Vantage Stereotactic System improves imaging and workflow for neurosurgery procedures 96
6.17 Sep 26, 2016: Qfix Encompass SRS Immobilization System is now validated and cleared for use with HyperArc High Definition Radiotherapy treatment delivery 97
6.18 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors 97
6.19 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 98
6.20 Sep 14, 2016: Misonix Appoints Interim CFO 99
6.21 Aug 31, 2016: MRI Interventions to Raise USD4.3 Million in Private Placement of Units 99
6.22 Aug 29, 2016: MEDTECH to Showcase Its ROSA Robot at Three Major International Congresses 99
6.23 Aug 29, 2016: Misonix President and Chief Executive Officer to Retire 100
6.24 Aug 25, 2016: Pivotal Study Results Published In New England Journal Of Medicine Confirm Safety And Efficacy Of Insightec’s Exablate Neuro System For The Treatment Of Essential Tremor 100
6.25 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 101
6.26 Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results 104
6.27 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire 107
6.28 Aug 12, 2016: Transgenomic Reports Second Quarter 2016 Financial Results 108
6.29 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 109
6.30 Aug 10, 2016: American Shared Hospital Services Reports 2016 Second Quarter Results 110
6.31 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results 111
6.32 Aug 02, 2016: Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook 112
6.33 Aug 01, 2016: Insightec Signs Distribution Agreements In Korea, Slovakia & Lithuania 114
6.34 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results 114
6.35 Jul 28, 2016: NEOS Surgery: New system to test the reliability of spine implants developed 115
6.36 Jul 27, 2016: Boston Scientific Acquires Cosman Medical 115
6.37 Jul 27, 2016: RTI Surgical Announces 2016 Second Quarter Results 116
6.38 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 117
6.39 Jul 26, 2016: Bard Announces Second Quarter Results 117
6.40 Jul 21, 2016: DNAtrix Announces Successful Intratumoral Delivery of DNX-2401 via Alcyone’s MEMS Cannula for the Targeted Treatment of Recurrent Glioblastoma 118
6.41 Jul 21, 2016: Stryker reports second quarter 2016 results 119
6.42 Jul 21, 2016: BrainScope Appoints Medical Device Industry Veteran Andrew Holman as Chief Commercial Officer 120
6.43 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 121
6.44 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 122
6.45 Jul 19, 2016: Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer 122
6.46 Jul 19, 2016: Medtech Fiscal 2016 Revenue Increases 73% To €11.2 Million 123
6.47 Jul 18, 2016: Zimmer Biomet Acquires 58.7% Stake in Medtech 123
6.48 Jul 11, 2016: FDA approves first MRI-guided focused ultrasound device to treat essential tremor 124
6.49 Jul 07, 2016: MEDTECH Announces the Sale of Thirteen New ROSA Robots in Fiscal Fourth Quarter 2016 125
6.50 Jul 06, 2016: U.S. patent trial and appeal board grants ZEISS’ petition and institutes IPR against NPE patent holder AMI 126
6.51 Jun 30, 2016: Cardinal Health Appoints Pamela O. Kimmet Chief Human Resources Officer 126
6.52 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 127
6.53 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance 127
6.54 Jun 28, 2016: Two Major Publications Reveal New Study Data Showing Patients with Deadliest Form of Stroke Now Have Second Chance at Life 128
6.55 Jun 24, 2016: Arkis BioSciences Raises USD3.4 Million in Series A Venture Financing 129
6.56 Jun 23, 2016: Medtech Announces Six New Global Sales of ROSA Brain Robot 129
6.57 Jun 17, 2016: New Clinical Study Will Evaluate MRI-Guided Laser Ablation for a Common Form of Epilepsy 130
6.58 Jun 06, 2016: Medtech’s ROSA Robot to be Featured at Three Major Congresses 131
6.59 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 132
6.60 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 132
6.61 May 24, 2016: Health Canada Approves Insightec’s Exablate Neuro System For The Treatment Of Essential Tremor 135
6.62 May 24, 2016: Transgenomic Reports First Quarter 2016 Financial Results 135
6.63 May 19, 2016: MEDTECH Announces First ROSA Spine Surgery in Spain 137
6.64 May 13, 2016: Optiscan Imaging announces Chief Executive Officer Appointment 137
6.65 May 12, 2016: IMRIS, Deerfield Imaging Announces New Department – Office of the Customer 138
6.66 May 11, 2016: MEDTECH Achieves 100th ROSA Spine Surgery Milestone 138
6.67 May 11, 2016: Carl Zeiss Meditec Records Revenue Growth of 8.6 Percent 139
6.68 May 11, 2016: Nephros Reports First Quarter 2016 Financial Results 140
6.69 May 10, 2016: Premier Health First in Nation to Use Minimally-Invasive Robotic System in Spine Surgery 141
6.70 May 10, 2016: American Shared Hospital Services Reports First Quarter Results 142
6.71 May 09, 2016: Penumbra Reports First Quarter 2016 Financial Results 143
6.72 May 05, 2016: Misonix Announces Third Quarter and Nine-Months 2016 Financial Results 143
6.73 May 03, 2016: MEDTECH Announces First ROSA Spine Surgery in the United States 145
6.74 May 03, 2016: Optiscan announces Board Changes 145
6.75 Apr 28, 2016: Brainlab Optimizes Planning Processes and Algorithms for Cranial Indications 146
6.76 Apr 27, 2016: Integra LifeSciences Reports First Quarter 2016 Financial Results 146
6.77 Apr 25, 2016: Medtech’s ROSA Robotic Surgery System to be Featured at the 84th American Association of Neurological Surgeons (AANS) Annual Meeting 147
6.78 Apr 14, 2016: Transgenomic Reports Full Year 2015 Financial Results 148
6.79 Apr 12, 2016: Optiscan announces Resignation of Chairman 149
6.80 Apr 07, 2016: Monteris Medical Receives IDE Approval From FDA To Evaluate NeuroBlate In Patients With Medically Refractory Epilepsy 150
6.81 Apr 05, 2016: MEDTECH Announces Sale of Ten New ROSA Robots in Fiscal Third Quarter 2016 150
6.82 Mar 23, 2016: INSIGHTEC Broadcasts The First, Live Exablate Neuro Brain Treatment At ISTU 2016 151
6.83 Mar 16, 2016: Vycor Medical Launches VBASMini 152
6.84 Mar 15, 2016: Polyganics appoints Dr Jan Ohrstrom to Supervisory Board 153
6.85 Mar 14, 2016: MEDTECH Announces New Sales of the ROSA Brain System in the United States and China 153
6.86 Mar 09, 2016: Medtech Announces First Sale of ROSA Spine in the United States to Miami Valley Hospital 154
6.87 Feb 29, 2016: MEDTECH to Demonstrate ROSA Brain system at American Academy of Orthopaedic Surgeons Annual Meeting 154
6.88 Feb 29, 2016: MEDTECH to Demonstrate ROSA Spine system at American Academy of Orthopaedic Surgeons Annual Meeting 155
6.89 Feb 26, 2016: MEDTECH Announces First Surgery With ROSA Robotic Surgery System in Australia 155
6.90 Feb 25, 2016: Krensavage Partners Acquires 6% Stake in RTI Surgical 155
6.91 Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance 156
6.92 Feb 23, 2016: Neurosurgery Device Maker Completes $15 Million Capital Raise to Address Increasing Market Demand of New Technologies for Tumor and Stroke 157
6.93 Feb 22, 2016: IMRIS, Deerfield Imaging Board of Directors Appoints Andrew M. Flanagan as Chief Executive Officer 158
6.94 Feb 15, 2016: New Sale of the ROSA Robotic Surgery System in France 158
6.95 Feb 10, 2016: Medtech’s Rosa Robotic Surgery System Featured at the Annual Meeting & Courses of the American Clinical Neurophysiology Society 159
6.96 Feb 10, 2016: Stryker Acquires Neuro Portfolio Assets of Synergetics 159
6.97 Feb 09, 2016: Misonix Announces Second Quarter Fiscal Year 2016 Financial Results 159
6.98 Feb 02, 2016: MEDTECH Announces Two New ROSA Sales in the U.S. 160
6.99 Jan 21, 2016: Polyganics Enters into Distribution Agreement with MicroAire Surgical Instruments 161
6.100 Jan 19, 2016: MEDTECH Strengthens Its U.S. Commercial Team to Support Launch of Rosa Spine 161
6.101 Jan 15, 2016: Brainlab Cranial IGS System: Class I Recall – Navigation Inaccuracy 161
6.102 Jan 13, 2016: NICO Announces Hemorrhagic Stroke Trial Lead by Emory University and Grady Memorial 162
6.103 Jan 05, 2016: MEDTECH Receives FDA Clearance for ROSA Spine 162
6.104 Jan 05, 2016: Eight New ROSA Robots Sold in Fiscal Q2 2016 163
6.105 Dec 15, 2015: ZEISS Ends Successful 2014/15 Fiscal Year 164
6.106 Dec 10, 2015: MicroTransponder Raises USD5.5 Million in Venture Financing 164
6.107 Dec 07, 2015: MEDTECH Announces the Sale of Two New ROSA Robotic Surgery Systems in the United States 164
7 Appendix 166
7.1 Methodology 166
7.2 About GlobalData 169
7.3 Contact Us 169
7.4 Disclaimer 169

1.1 List of Tables
Table 1: Neurosurgical Products - Pipeline Products by Stage of Development 13
Table 2: Neurosurgical Products - Pipeline Products by Segment 14
Table 3: Neurosurgical Products - Pipeline Products by Territory 15
Table 4: Neurosurgical Products - Pipeline Products by Regulatory Path 16
Table 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date 17
Table 6: Neurosurgical Products - Ongoing Clinical Trials 18
Table 7: Neurosurgical Products Companies - Pipeline Products by Stage of Development 19
Table 8: Neurosurgical Products - Pipeline Products by Stage of Development 21
Table 9: Accurexa Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 10: BranchPoint Device - Product Status 23
Table 11: BranchPoint Device - Product Description 23
Table 12: Augusta University Pipeline Products & Ongoing Clinical Trials Overview 24
Table 13: Surgical Instrument - Neurological Procedures - Product Status 24
Table 14: Surgical Instrument - Neurological Procedures - Product Description 24
Table 15: BioArctic Neuroscience AB Pipeline Products & Ongoing Clinical Trials Overview 25
Table 16: Spinal Cord Injury FGF1/Device SC0806 - Product Status 25
Table 17: Spinal Cord Injury FGF1/Device SC0806 - Product Description 25
Table 18: BioArctic Neuroscience AB - Ongoing Clinical Trials Overview 26
Table 19: Spinal Cord Injury FGF1/Device SC0806 - An Open, Randomized, Rehabilitation-controlled Study to Assess Safety, Tolerability, and Efficacy of Heparin Activated Recombinant Fibroblast Growth Factor 1 on a Biodegradable Device in Subjects with Traumatic Spinal Cord Injury 26
Table 20: C2C Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 27
Table 21: NAViTECH Streamlined Device - Product Status 27
Table 22: NAViTECH Streamlined Device - Product Description 27
Table 23: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 28
Table 24: Hydrosurgery System - Product Status 28
Table 25: Hydrosurgery System - Product Description 28
Table 26: Carthera SAS Pipeline Products & Ongoing Clinical Trials Overview 29
Table 27: SonoCloud - Product Status 29
Table 28: SonoCloud - Product Description 30
Table 29: SonoProbe - Product Status 30
Table 30: SonoProbe - Product Description 30
Table 31: Carthera SAS - Ongoing Clinical Trials Overview 31
Table 32: SonoCloud - A Study to Evaluate the Safety of Transient Opening of the Blood-brain Barrier by Low Intensity Pulsed Ultrasound with the SonoCloud Implantable Device in Patients with Recurrent Glioblastoma Before Chemotherapy Administration 31
Table 33: Cizeta Surgical Pipeline Products & Ongoing Clinical Trials Overview 32
Table 34: SKULL GRIP - Product Status 32
Table 35: SKULL GRIP - Product Description 32
Table 36: Cornell University Pipeline Products & Ongoing Clinical Trials Overview 33
Table 37: Tightly-Focused Femtosecond Laser - Product Status 33
Table 38: Tightly-Focused Femtosecond Laser - Product Description 33
Table 39: DiversiLabs, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
Table 40: SAlinac System - Product Status 34
Table 41: SAlinac System - Product Description 35
Table 42: Elekta AB Pipeline Products & Ongoing Clinical Trials Overview 36
Table 43: Leksell Vantage Stereotactic System - Product Status 36
Table 44: Leksell Vantage Stereotactic System - Product Description 37
Table 45: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 38
Table 46: MIFUS Device - Product Status 38
Table 47: MIFUS Device - Product Description 38
Table 48: InSightec Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 49: ExAblate Neuro - Product Status 39
Table 50: ExAblate Neuro - Product Description 40
Table 51: InSightec Ltd - Ongoing Clinical Trials Overview 41
Table 52: ExAblate Neuro - A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects 43
Table 53: ExAblate Neuro - A Feasibility Clinical Trial of the Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for the Management of Treatment-refractory Movement Disorders 43
Table 54: ExAblate Neuro - A Feasibility Clinical Trial of the Management of the Medically-refractory Dyskinesia Symptoms of Advanced Idiopathic Parkinson's Disease with Unilateral Lesioning of the Globus Pallidum Using the ExAblate Transcranial System 43
Table 55: ExAblate Neuro - A Feasibility Clinical Trial of the Management of the Medically-refractory Motor Symptoms of Advanced Idiopathic Parkinson's Disease with Staged, Unilateral Lesioning of the Subthalamic Nucleus using the ExAblate Transcranial System 44
Table 56: ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Bilateral Anterior Capsulotomy in the Treatment of Medication-refractory MDD 44
Table 57: ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Medication-refractory Tremor Dominant Idiopathic Parkinson's Disease 45
Table 58: ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound Treatment of Medication-refractory OCD 45
Table 59: ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of MR-Guided Focused Ultrasound Ablation Therapy in the Treatment of Subcortical Lesional Epilepsy 45
Table 60: ExAblate Neuro - A Pivotal Study to Evaluate the Effectiveness and Safety of Exablate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects 46
Table 61: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 47
Table 62: Cranial Access Kit - Product Status 47
Table 63: Cranial Access Kit - Product Description 48
Table 64: CUSA System - Product Status 48
Table 65: CUSA System - Product Description 48
Table 66: MAYFIELD Composite - Product Status 49
Table 67: MAYFIELD Composite - Product Description 49
Table 68: Stereotaxy Device - Product Status 49
Table 69: Stereotaxy Device - Product Description 50
Table 70: International HIFU Pipeline Products & Ongoing Clinical Trials Overview 51
Table 71: Focused Ultrasound System - Product Status 51
Table 72: Focused Ultrasound System - Product Description 51
Table 73: JetGuide Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 74: JetGuide System - Neuro - Product Status 52
Table 75: JetGuide System - Neuro - Product Description 52
Table 76: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 53
Table 77: Minimally Invasive Neurology/Neurosurgery Device - Product Status 53
Table 78: Minimally Invasive Neurology/Neurosurgery Device - Product Description 53
Table 79: Stereotactic-guided Laser Ablation System - Product Status 54
Table 80: Stereotactic-guided Laser Ablation System - Product Description 54
Table 81: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 82: Recranio - Product Status 55
Table 83: Recranio - Product Description 55
Table 84: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 85: Stealth Station S8 - Product Status 56
Table 86: Stealth Station S8 - Product Description 57
Table 87: Visualase System - Brain Tumor - Product Status 57
Table 88: Visualase System - Brain Tumor - Product Description 57
Table 89: Visualase System - Epilepsy - Product Status 58
Table 90: Visualase System - Epilepsy - Product Description 58
Table 91: Medtronic plc - Ongoing Clinical Trials Overview 58
Table 92: Visualase System - Brain Tumor - LITT for the Treatment of Newly Diagnosed Central Nervous System Tumors Located in Difficult to Surgically Access Regions of the Brain and Recurrent/resistant Pediatric Central Nervous System Tumors Located Anywhere within the Brain 59
Table 93: Visualase System - Epilepsy - Stereotactic Laser Ablation for Temporal Lobe Epilepsy 59
Table 94: Monteris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 95: NeuroBlate System - Medically Refractory Epilepsy - Product Status 60
Table 96: NeuroBlate System - Medically Refractory Epilepsy - Product Description 60
Table 97: Monteris Medical Inc - Ongoing Clinical Trials Overview 61
Table 98: NeuroBlate System - Medically Refractory Epilepsy - Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE) 61
Table 99: MRC Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 62
Table 100: Multilas - Product Status 62
Table 101: Multilas - Product Description 62
Table 102: NICO Corporation Pipeline Products & Ongoing Clinical Trials Overview 63
Table 103: Neurosurgery Device - Glioblastoma Multiforme - Product Status 63
Table 104: Neurosurgery Device - Glioblastoma Multiforme - Product Description 63
Table 105: Optiscan Imaging Limited Pipeline Products & Ongoing Clinical Trials Overview 64
Table 106: Neurosurgical Endomicroscopy System - Product Status 64
Table 107: Neurosurgical Endomicroscopy System - Product Description 65
Table 108: PediaWorks Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 109: Neurosurgery Resector - Product Status 66
Table 110: Neurosurgery Resector - Product Description 66
Table 111: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67
Table 112: Neural Implant - Product Status 67
Table 113: Neural Implant - Product Description 67
Table 114: Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 68
Table 115: Craniotomy Suture Passer - Product Status 68
Table 116: Craniotomy Suture Passer - Product Description 68
Table 117: StereoTools SA Pipeline Products & Ongoing Clinical Trials Overview 69
Table 118: StereoPod - Product Status 69
Table 119: StereoPod - Product Description 69
Table 120: The Swedish Neuroscience Institute Pipeline Products & Ongoing Clinical Trials Overview 70
Table 121: MR-guided Focused Ultrasound System - Product Status 70
Table 122: MR-guided Focused Ultrasound System - Product Description 70
Table 123: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 71
Table 124: Computer-Controlled Surgical Cutting Tool - Product Status 71
Table 125: Computer-Controlled Surgical Cutting Tool - Product Description 71
Table 126: Hollow Artificial Conduit - Product Status 72
Table 127: Hollow Artificial Conduit - Product Description 72
Table 128: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 73
Table 129: Stereotactic Insertion Guidance System - Product Status 73
Table 130: Stereotactic Insertion Guidance System - Product Description 73
Table 131: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 74
Table 132: Denver Surgical Corridor - Product Status 74
Table 133: Denver Surgical Corridor - Product Description 74
Table 134: University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 75
Table 135: Minimally Invasive Neurosurgical Intracranial Robot - Product Status 75
Table 136: Minimally Invasive Neurosurgical Intracranial Robot - Product Description 75
Table 137: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 76
Table 138: Dural Knife With Protective Foot-Plate - Product Status 76
Table 139: Dural Knife With Protective Foot-Plate - Product Description 76
Table 140: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 77
Table 141: Endoscope With Stimulating Electrode - Product Status 77
Table 142: Endoscope With Stimulating Electrode - Product Description 77
Table 143: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 78
Table 144: Flat-Cut Bit For Cranial Perforator - Product Status 78
Table 145: Flat-Cut Bit For Cranial Perforator - Product Description 78
Table 146: PosiSeat - Product Status 79
Table 147: PosiSeat - Product Description 79
Table 148: Xylos Corporation Pipeline Products & Ongoing Clinical Trials Overview 80
Table 149: Dura Replacement Device - Product Status 80
Table 150: Dura Replacement Device - Product Description 80
Table 151: Glossary 167

1.2 List of Figures
Figure 1: Neurosurgical Products - Pipeline Products by Stage of Development 13
Figure 2: Neurosurgical Products - Pipeline Products by Segment 14
Figure 3: Neurosurgical Products - Pipeline Products by Territory 15
Figure 4: Neurosurgical Products - Pipeline Products by Regulatory Path 16
Figure 5: Neurosurgical Products - Pipeline Products by Estimated Approval Date 17
Figure 6: Neurosurgical Products - Ongoing Clinical Trials 18

【掲載企業】

Accurexa Inc.
Augusta University
BioArctic Neuroscience AB
C2C Development, LLC
Carnegie Mellon University
Carthera SAS
Cizeta Surgical
Cornell University
DiversiLabs, LLC
Elekta AB
Hadassah Medical Center
InSightec Ltd
Integra LifeSciences Holdings Corp
International HIFU
JetGuide Ltd.
Mayo Clinic US
Medprin Regenerative Medical Technologies Co Ltd
Medtronic plc
Monteris Medical Inc
MRC Systems GmbH
NICO Corporation
Optiscan Imaging Limited
PediaWorks Inc
Replication Medical Inc
Resultados y Calidad del Sistema Sanitario Publico de Andalucia
StereoTools SA
The Swedish Neuroscience Institute
The University of Utah
University of California San Francisco
University of Colorado
University of Maryland Baltimore
University of South Florida
University of Texas Medical Branch at Galveston
Vanderbilt University
Xylos Corporation

【レポートのキーワード】

神経外科製品

★調査レポート[世界の神経外科製品市場:医療機器パイプライン分析2016] (コード:GDME0287EPD)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の神経外科製品市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆